These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 18404682)

  • 1. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
    Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
    Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
    Majid S; Dar AA; Ahmad AE; Hirata H; Kawakami K; Shahryari V; Saini S; Tanaka Y; Dahiya AV; Khatri G; Dahiya R
    Carcinogenesis; 2009 Apr; 30(4):662-70. PubMed ID: 19221000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation.
    Oyer JA; Yates PA; Godsey S; Turker MS
    Mutat Res; 2011 Jan; 706(1-2):21-7. PubMed ID: 21035468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
    Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
    PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
    Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST
    Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
    Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
    Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines.
    Ikehata M; Ueda K; Iwakawa S
    Biol Pharm Bull; 2012; 35(3):301-7. PubMed ID: 22382314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
    Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
    Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
    Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
    Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
    Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
    Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
    Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
    Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
    Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
    Jiang X; Tan J; Li J; Kivimäe S; Yang X; Zhuang L; Lee PL; Chan MT; Stanton LW; Liu ET; Cheyette BN; Yu Q
    Cancer Cell; 2008 Jun; 13(6):529-41. PubMed ID: 18538736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
    Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
    Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.